Anzeige
Meldung des Tages: Breaking News - Der Breakthrough, der eines der größten Probleme der Elektromobilität lösen könnte?

Cambiar Aggressive Value ETF News

ETF
WKN:  ISIN:  US0075W01639 US-Symbol:  CAMX
30,398 €
-0,18 $
-0,52%
30,398 € 14.07.26
Depot/Watchlist
Indexbildung
Ertragsverwendung
-
Lfd. Kosten
-
Fondsgröße
-  
Tracking Error
-
Währung
FWW Fundstars
keine Bewertung

Cambiar Aggressive Value ETF News

17.07.26 - PR Newswire
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA PR Newswire
17.07.26 - PR Newswire
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA PR Newswire
01.06.26 - PR Newswire
Camurus announces expansion of Lilly collaboration
Camurus announces expansion of Lilly collaboration PR Newswire
01.06.26 - PR Newswire
Camurus announces expansion of Lilly collaboration
Camurus announces expansion of Lilly collaboration PR Newswire
09.01.26 - PR Newswire
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly PR Newswire
09.01.26 - PR Newswire
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly PR Newswire
10.11.25 - PR Newswire
Camurus reports positive topline results for CAM2056, semaglutide monthly depot
Camurus reports positive topline results for CAM2056, semaglutide monthly depot PR Newswire
10.11.25 - PR Newswire
Camurus reports positive topline results for CAM2056, semaglutide monthly depot
Camurus reports positive topline results for CAM2056, semaglutide monthly depot PR Newswire
28.08.25 - PR Newswire
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK PR Newswire

Newssuche

Videos

newspaper
12:20 Uhr
INSIDER FLASH STRATEGY Einführung
Live-​Seminar am 2.8. ab 14 Uhr (Unterlagen und Aufzeichnung werden danach ausgehändigt). Vorab-... Mehr »